General Medicine Flashcards

1
Q

Biguanide MoA

A

Decerase insulin resistance and hepatic glcose production.

Limit weight gain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Biguanide Efficacy

A
  • 1-2%
  • Can be used with others
  • Little side effects
  • Low cost
  • No hypoglycaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Biguanide side effect

A
  • Little or no weight gain
  • GI
  • Lactic acidosis (with resp, CVD, Renal) HRH
  • Vit B12 (absorption)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sulphonylureas drugs used`

A

Gliclazide
Glibenclamide
Glimepiride
Tolbutamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sulphonylureas MoA

A

Stimulate B cells to release insulin. Antagonise B cell K/ATP channel activity, increase in K (as it accumulates) so depolarisation. Increased Ca, increased release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sulphonylureas efficacy

A
  • 1-2%
  • Low cost
  • Tolbutamide has good post prandial control as it has a short half life so taken 30mins before.
  • Others have higher half life and more potent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Sulphonylureas side effect

A
  • Weight gain

* Hypoglycaemia (especially CKD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Glitazone (TZDs) example

A

Pioglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Glitazone (TZDs) MoA

A

Increase sensitivity in muscle and adipose tissue. (via upregulation of signals/ genes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Glitazone ADRs

A
•	Wegith
•	Fluid (HF)
•	Bone metab (osteoporosis)
•	Bladder cancer
•	Hoever don’t get hypos
•	Increase in LDL and HDL
Rarely used now
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe Gliptins and e.gs

A
Sitagliptin
Vildagliptin
Saxagliptin
Linagliptin
•	0.5-0.8
•	Weight loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Gliptins ADRs

A
•	GI symptoms
•	High cost so 2nd line
•	Infection
Pancreatitis
Hypos rare
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

GLP-1 agonists e.g.s MoA, efficacy

A

Exenatide Liraglutide
GLP from intestine increases insulin secretion and biosynthesis, decreases glucagon secretion, decreases liver glucose production (indirectly).
Decreases satiety, decreases gastric emptying.
Increases glucose uptake into muscles (indirect)
1-=1.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

GLP-1 ADRS

A
  • GI, nausea, loose stools, diarrhoea
  • GORD
  • Painful to inject
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

SGLT2 e.g.s

A

Dapagliflozin
Canagliflozin
Empagliflozin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

SGLT2 MoA and efficacy

A

Prevents glucose absorption in the the PCT by SGLT2 (90%)

0.5-1%

17
Q

SGLT2 ADRS

A
•	Only one extra void a day
•	UTI, thrush
•	Polyuria
•	Hypo (low risk)
Urosepsis
One one episode of above
18
Q

Rapid acting insulin onset and name

A
Insulin Aspart (Novorapid)
Insulin Lispro (Humalog)
Insulin Glulisine (Apidra)
o 5-15
P: 30-60min
D: 3-4hr
19
Q

Short acting

A

Humulin S
Actrapid
Insuman Rapid

O: 30-60
P: 2-3
D: 6-8

20
Q

Intermediate acting

A

Humulin I
Insuman Basal
Insulatard
Isophane (NPH)

O: 1-2
P: 4-6
D: 14-16h

21
Q

Long acting

A

Insulin glargine (Lantus); Abasaglar
O: 2-4h
No peak
D@ 20-24h

Insulin Detemir (levimer) Analogue
O:2-4
P: 6-14
D: 16-20

22
Q

Importance of insulin Toujeo(R)

A

High strength insulin
Basal once daily
exlusive units
Glargine but flatter peak than other glargine products e.g. Lantus
Always prescribe by brand name and include the concentration of insulin

23
Q

What is Degludec

A

Long acting

U100 and U200

24
Q

What is Humulin R (resistant)

A
Very potent
U500 - 5x stronger than normal insulin
For insulin resistant patients
Normally TDS before meals
Prescribed in marks not U
Marks based on 0.3 or 0.5ml insulin syringe. 1 mark = 0.01ml = 5 units
25
Q

Who needs insulin infusion?

A
DKA
HHS - Hypersmolar hyperglycaemic state
Surgical patients - NBM and missing more tna one meal
Vomiting
Major vasc event - ACS and Post CVA
TPN/ entral fed patients
Steroid use
Metabolically unwell not eating and drinking
-most cortisol related
26
Q

Difficulties of IV insulin

A

x

27
Q

Limitations to IV insulin

A

x

28
Q

Practical aspects of IV insulin. What would you do?

A

To make 50 units of Human Actrapid
50 units of actrapid and 49.5ml of NaCl aline ina 50ml luer lock syringe so conc of 1unit/1ml
Non returnable valve
No more than 24 hrs as crystalises
Volumetric pump used
Rate used that gives 6-10mmols/L of glucose
Discard after 24hrs
In most cases needs substrate (glucose)
Different degrees of insulin sensitivity accounted for
Patients have different sensitivities to insulin to adjust accordingly related to weight, concurrent illness and medication (steroids)
Tables for rate guides
CBGs done hourly for first 24h

29
Q

Ketone monitoring in IV insulin

A

Monitor ketones in T1 if glucose >12 on 2 readings 1 hr apart
T2 - Monitor if unwell, get a baseline

30
Q

Treatmeny of hypos from IV insulin

A

CBG <4mmols/L
Stop insulin
Give 75mls of 20% glucose IV over 15 minutes or equivalent
Repeat CBG and if needed treatment
Once above 4mmol/L restart IV insulin with a review of dose

31
Q

Which patients should be kept over 6mmols/L during IV insulin

A

In patients with ACS or stroke do not let CBGs drop below 6

32
Q

Explain concurrent fluids with IV insulin

A

0.9% saline if vomiting, pyrexial, dehydrated with glucose
If HF or renal, no saline due to overload. Elderly too
Replace electrolytes with NaCl and KCl if on insulin for prolonged period

33
Q

Explain discontinuation proceedure for IV insulin

A

Stop 30 mins after usual diabetes treatment begins and patient can eat and drink
Check CBGs after 1 hr and 4x in next 24 hrs - rebound hyperglycaemia